Cuneo, Antonio <br/><br/>
Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: a GIMEMA, ERIC and UK CLL FORUM study.  [electronic resource] 

 -  Haematologica  07 2018 
 - 1209-1217 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1592-8721 
<br/><br/><label>Standard No.: </label>10.3324/haematol.2018.189837  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenine--analogs & derivatives<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Bendamustine Hydrochloride--administration & dosage<br/>Biomarkers, Tumor<br/>Humans<br/>Italy<br/>Leukemia, Lymphocytic, Chronic, B-Cell--diagnosis<br/>Middle Aged<br/>Piperidines<br/>Prognosis<br/>Pyrazoles--administration & dosage<br/>Pyrimidines--administration & dosage<br/>Retreatment<br/>Rituximab--administration & dosage<br/>Salvage Therapy<br/>Survival Analysis<br/>Treatment Outcome<br/>United Kingdom